• OPEN AN ACCOUNT
Indian Indices
Sensex
71,909.70 -570.59
( -0.79%)
Global Indices
Nasdaq
50,952.25 25.20
(0.05%)
Dow Jones
7,687.74 15.20
(0.20%)
Hang Seng
68,256.51 -700.21
(-1.02%)
Nikkei 225
10,455.36 27.09
(0.26%)
Forex
USD-INR
95.92 -0.05
(-0.05%)
EUR-INR
108.79 -0.10
(-0.09%)
GBP-INR
127.19 0.21
(0.17%)
JPY-INR
0.61 0.00
(0.14%)

EQUITY - MARKET SCREENER

Tata Consultancy Services Ltd
Industry :  Computers - Software - Large
BSE Code
ISIN Demat
Book Value()
532540
INE467B01029
234.0734112
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
TCS
13.97
752308.94
EPS(TTM)
Face Value()
Div & Yield %
148.84
1
5.29
 

Lupin receives USFDA approval for Pitolisant Tablets, 4.45 mg and 17.8 mg
Aug 17,2026
Lupin has received the final approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Pitolisant Tablets, 4.45 mg and 17.8 mg.

The U.S. FDA has approved Lupin's Pitolisant Tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix® for the indications in the approved labeling.